characteristics.text: SAMN46294473
characteristics.characteristic: External Id
characteristics.text: Klco, Pathology, St Jude Children's Research Hospital
characteristics.characteristic: INSDC center name
characteristics.text: 2025-07-24T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2025-07-24T15:06:05.816Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS23821053
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS23821053
characteristics.characteristic: SRA accession
characteristics.text: NA
characteristics.characteristic: cell line
characteristics.text: cord blood CD34+ cell
characteristics.characteristic: cell type
characteristics.text: missing
characteristics.characteristic: collection_date
characteristics.text: NA
characteristics.characteristic: genotype
characteristics.text: missing
characteristics.characteristic: geo_loc_name
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: NA
characteristics.characteristic: source_name
characteristics.text: 7
characteristics.characteristic: time
characteristics.text: cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (RB1-gRNA1) + Revumenib (1 uM)-treatment (7 days) batch 2 rep3
characteristics.characteristic: title
characteristics.text: constitutive expression of NUP98::KDM5A and Cas9 + lentiviral transduction of gRNA (RB1-gRNA1) + Revumenib (1 uM)-treatment (7 days)
characteristics.characteristic: treatment